Industrial Alliance Investment Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,236
Closed -$3.57M 379
2023
Q1
$3.57M Buy
23,236
+985
+4% +$162K 0.1% 166
2022
Q4
$4M Sell
22,251
-2,134
-9% -$349K 0.11% 160
2022
Q3
$2.88M Buy
24,385
+524
+2% +$79.5K 0.08% 188
2022
Q2
$3.41M Buy
23,861
+658
+3% +$94.1K 0.1% 175
2022
Q1
$4M Sell
23,203
-5,700
-20% -$960K 0.09% 179
2021
Q4
$7.34M Buy
+28,903
New +$8.45M 0.17% 124

Other funds holding MRNA

Industrial Alliance Investment Management's MRNA Position: Q2 2023 in Review

Industrial Alliance Investment Management sold out of Moderna (MRNA) in Q2 2023, closing a stake of 23,236 shares — an estimated $3.57M sold.

Industrial Alliance Investment Management first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $7.34M in Q4 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Industrial Alliance Investment Management reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 23,236 Moderna shares in Q2 2023, an estimated $3.57M.
  • Industrial Alliance Investment Management first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Industrial Alliance Investment Management's Moderna position peaked at $7.34M in Q4 2021.
  • 967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.